Main content
Sorry, this episode is not currently available

Pfizer boss: UK cancer survival rate 'lagging'

The managing director of Pfizer UK Erik Nordkamp says he would not want to be a cancer patient in England.

Today the government's consultation on the new shape of the Cancer Drugs Fund will come to an end.

The managing director of Pfizer UK Erik Nordkamp explained on the Today programme why he has said he would not want to be a cancer patient in England.

"The survival rate in the UK...is really lagging behind," he said.

鈥淚f you look at the economic climate in the UK鈥here is a relationship between business sentiment鈥nd the fairly hostile environment for the uptake of innovative medicines in the UK.鈥�

7 minutes

More episodes

See all episodes from Best of Today

Podcast

  • Best of Today

    Listen to selected highlights from the Today programme.